Mitsubishi UFJ Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50
Closed -$4.92K 1607
2025
Q2
$4.92K Hold
50
﹤0.01% 1465
2025
Q1
$4.63K Hold
50
﹤0.01% 1452
2024
Q4
$4.56K Hold
50
﹤0.01% 1463
2024
Q3
$4.83K Hold
50
﹤0.01% 1423
2024
Q2
$4.59K Hold
50
﹤0.01% 1387
2024
Q1
$4.61K Hold
50
﹤0.01% 1356
2023
Q4
$4.73K Hold
50
﹤0.01% 1318
2023
Q3
$4.67K Buy
+50
New +$4.62K ﹤0.01% 1277

Other funds holding AMED

Mitsubishi UFJ Asset Management's AMED Position: Q3 2025 in Review

Mitsubishi UFJ Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 50 shares — an estimated $4.92K sold.

Mitsubishi UFJ Asset Management first reported a position in AMED in Q3 2023 and held it in 8 quarters. The position peaked at $4.92K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Mitsubishi UFJ Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 50 Amedisys shares in Q3 2025, an estimated $4.92K.
  • Mitsubishi UFJ Asset Management first reported a position in Amedisys in Q3 2023 and held it in 8 quarters.
  • Mitsubishi UFJ Asset Management's Amedisys position peaked at $4.92K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.